Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL7722238 | 0.98 | BCHE (0.44) | ACHEBCHE | |
| Iodide SCHEMBL10722217 | 0.98 | ACHE (0.41) | ACHEBCHE | |
| SCHEMBL9809178 | 0.79 | HTT (0.42) | ACHEBCHE | |
| SCHEMBL15631174 | 0.78 | GABRA1 (0.38) | — | |
| SCHEMBL15631176 | 0.78 | KCNN2 (0.40) | ACHEBCHE | |
| SCHEMBL15631167 | 0.78 | UGT2B7 (0.40) | — | |
| SCHEMBL15631160 | 0.75 | UGT2B7 (0.37) | — | |
| SCHEMBL17428423 | 0.75 | ACHE (0.38) | ACHEBCHE | |
| SCHEMBL17191925 | 0.72 | ALOX15 (0.31) | — | |
| SCHEMBL15631171 | 0.71 | CYP1A2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4580855-A | COOLING TO SOLIDIFY 7,7,8,8-TETRACYANOQUINODIMETHANE COMPLEX SALT | SANYO ELECTRIC CO., LTD. (JP) | 1986-04-08 | — | — | US | claimed |
| US-11696912-B2 | Charged ion channel blockers and methods for use | Nocion Therapeutics, Inc. (US) | 2023-07-11 | — | — | US | disclosed |
| US-11696912-B2 | Charged ion channel blockers and methods for use | Nocion Therapeutics, Inc. (US) | 2023-07-11 | — | — | US | disclosed |
| US-20200259085-A1 | TREATMENT LIQUID CONTAINING IONIC COMPOUND, ORGANIC ELECTRONIC ELEMENT, AND METHOD FOR PRODUCING ORGANIC ELECTRONIC ELEMENT | HITACHI CHEMICAL COMPANY, LTD. | 2020-08-13 | — | — | US | disclosed |
| CN-106939074-B | Treatment liquid containing ionic compound | 日立化成株式会社 | 2020-06-16 | — | — | CN | disclosed |
| US-10665786-B2 | Treatment liquid containing ionic compound, organic electronic element, and method for producing organic electronic element | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2020-05-26 | — | — | US | disclosed |
| US-20200143954-A1 | ORGANIC ELECTRONIC MATERIAL, POLYMERIZATION INITIATOR AND THERMAL POLYMERIZATION INITIATOR, INK COMPOSITION, ORGANIC THIN FILM AND PRODUCTION METHOD FOR SAME, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, DISPLAY ELEMENT, AND DISPLAY DEVICE | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2020-05-07 | — | — | US | disclosed |
| US-10566105-B2 | Method for producing charge transport film | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2020-02-18 | — | — | US | disclosed |
| US-9583714-B2 | Material for organic electronics, organic electronic element, organic electroluminescent element, display element using organic electroluminescent element, illuminating device, and display device | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2017-02-28 | — | — | US | disclosed |
| US-20160020395-A1 | TREATMENT LIQUID CONTAINING IONIC COMPOUND, ORGANIC ELECTRONIC ELEMENT, AND METHOD FOR PRODUCING ORGANIC ELECTRONIC ELEMENT | RESONAC CORPORATION (JP) | 2016-01-21 | — | — | US | disclosed |
| US-20090163555-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | PRODIMED, S.A. (ES) | 2009-06-25 | — | — | US | disclosed |
| US-20070249678-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | PRODIMED, S.A. (ES) | 2007-10-25 | — | — | US | disclosed |
| US-20070225458-A1 | Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex | SAN-APRO LIMITED (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1752463-A1 | NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX | San-Apro Limited (JP) | 2007-02-14 | — | — | EP | disclosed |
| EP-0152082-B1 | AN ORGANIC SEMICONDUCTOR ELECTROLYTE CAPACITOR AND PROCESS FOR PRODUCING THE SAME | NIPPON CHEMI-CON CORPORATION (JP) | 1989-05-03 | — | — | EP | disclosed |
| US-4735823-A | ELECTROLYTE IS MIXTURE OF ISOPROPYLQUINOLIDIUM TETRACYANOQUINODIMETHANE COMPLEX AND A LACTONE | NIPPON CHEMI-CON CORPORATION (JP) | 1988-04-05 | — | — | US | disclosed |
| EP-0236842-A2 | Fusible electrically conductive mixtures | BAYER AG (DE) | 1987-09-16 | — | — | EP | disclosed |
| US-4656560-A | MIXTURE OF ISOPROPYLISOQUINOLINIUM TETRACYANOQUINODIMETHANE COMPLEX WITH A LACTONE | NIPPON CHEMI-CON CORPORATION (JP) | 1987-04-07 | — | — | US | disclosed |
| US-4580855-A | COOLING TO SOLIDIFY 7,7,8,8-TETRACYANOQUINODIMETHANE COMPLEX SALT | SANYO ELECTRIC CO., LTD. (JP) | 1986-04-08 | — | — | US | disclosed |
| EP-0152082-A2 | An organic semiconductor electrolyte capacitor and process for producing the same | NIPPON CHEMI-CON CORPORATION (JP) | 1985-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249678-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | GLUL, RIMKLA, PHKG1 | ACHE 4329/4885BCHE 2073/4885 |
| US-20090163555-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | GLUL, RIMKLA, GLS | ACHE 4188/4885BCHE 2328/4885 |
| US-11696912-B2 | Charged ion channel blockers and methods for use | TRPV1, ASIC1, TRPA1 | ACHE 338/4885BCHE 1318/4885 |
| US-20070225458-A1 | Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex | AS3MT, TTR, PFAS | ACHE 3109/4885BCHE 4469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.